| This subject phenotype table contains subject IDs, sex, age at the recruitment, height, weight, warfarin daily and weekly doses, if warfarin was indicated to manage deep vein thrombosis (DVT), pulmonary embolism (PE), atrial fibrillation (AF), mechanical heart valve replacement, and stroke, if the patient has diabetes, congestive heart failure, and other conditions, if the patient uses aspirin, statins, and medications containing azoles, if the patient smokes, African, Caucasian and Native (Zapotecas) parental proportions, and if the patient is sensitive (requires <4mg/day) or resistant (requires >6mg/day) to warfarin. | If the patient is resistant to warfarin | phv00352973.v1.p1 |
| This subject phenotype table contains subject IDs, sex, age at the recruitment, height, weight, warfarin daily and weekly doses, if warfarin was indicated to manage deep vein thrombosis (DVT), pulmonary embolism (PE), atrial fibrillation (AF), mechanical heart valve replacement, and stroke, if the patient has diabetes, congestive heart failure, and other conditions, if the patient uses aspirin, statins, and medications containing azoles, if the patient smokes, African, Caucasian and Native (Zapotecas) parental proportions, and if the patient is sensitive (requires <4mg/day) or resistant (requires >6mg/day) to warfarin. | If the patient is sensitive to warfarin | phv00352972.v1.p1 |
| This sample attributes table contains subject IDs, sample IDs, body site, analyte type, tumor status, histological type, analysis type, genotyping and sequencing technologies, and name of the centers which conducted genotyping or sequencing. | Tumor status | phv00347738.v1.p1 |
| The subject consent file includes subject IDs, consent information, subject aliases, and case control status of the subject for Warfarin Sensitivity. | Consent group as determined by DAC | phv00347703.v1.p1 |
| The subject consent file includes subject IDs, consent information, subject aliases, and case control status of the subject for Warfarin Sensitivity. | Case control status of the subject for Warfarin Sensitivity. Controls are subjects with warfarin requirements of 4-6mg/day. Cases are subjects with warfarin stable dose <4mg/day or >6mg/day | phv00347706.v1.p1 |
| This subject phenotype table contains subject IDs, sex, age at the recruitment, height, weight, warfarin daily and weekly doses, if warfarin was indicated to manage deep vein thrombosis (DVT), pulmonary embolism (PE), atrial fibrillation (AF), mechanical heart valve replacement, and stroke, if the patient has diabetes, congestive heart failure, and other conditions, if the patient uses aspirin, statins, and medications containing azoles, if the patient smokes, African, Caucasian and Native (Zapotecas) parental proportions, and if the patient is sensitive (requires <4mg/day) or resistant (requires >6mg/day) to warfarin. | If the patient uses medications containing azoles | phv00347729.v1.p1 |
| This data table contains a mapping of study subject IDs to sample IDs. Samples are the final preps submitted for genotyping, sequencing, and/or expression data. For example, if one patient (subject ID) gave one sample, and that sample was processed differently to generate 2 sequencing runs, there would be two rows, both using the same subject ID, but having 2 unique sample IDs. The data table also includes sample aliases and sample use. | Source repository where samples originate | phv00347709.v1.p1 |
| This subject phenotype table contains subject IDs, sex, age at the recruitment, height, weight, warfarin daily and weekly doses, if warfarin was indicated to manage deep vein thrombosis (DVT), pulmonary embolism (PE), atrial fibrillation (AF), mechanical heart valve replacement, and stroke, if the patient has diabetes, congestive heart failure, and other conditions, if the patient uses aspirin, statins, and medications containing azoles, if the patient smokes, African, Caucasian and Native (Zapotecas) parental proportions, and if the patient is sensitive (requires <4mg/day) or resistant (requires >6mg/day) to warfarin. | Caucasian parental proportion | phv00347732.v1.p1 |
| This sample attributes table contains subject IDs, sample IDs, body site, analyte type, tumor status, histological type, analysis type, genotyping and sequencing technologies, and name of the centers which conducted genotyping or sequencing. | De-identified Sample ID | phv00347735.v1.p1 |
| This subject phenotype table contains subject IDs, sex, age at the recruitment, height, weight, warfarin daily and weekly doses, if warfarin was indicated to manage deep vein thrombosis (DVT), pulmonary embolism (PE), atrial fibrillation (AF), mechanical heart valve replacement, and stroke, if the patient has diabetes, congestive heart failure, and other conditions, if the patient uses aspirin, statins, and medications containing azoles, if the patient smokes, African, Caucasian and Native (Zapotecas) parental proportions, and if the patient is sensitive (requires <4mg/day) or resistant (requires >6mg/day) to warfarin. | Weight at the moment of giving informed consent | phv00347716.v1.p1 |
| This subject phenotype table contains subject IDs, sex, age at the recruitment, height, weight, warfarin daily and weekly doses, if warfarin was indicated to manage deep vein thrombosis (DVT), pulmonary embolism (PE), atrial fibrillation (AF), mechanical heart valve replacement, and stroke, if the patient has diabetes, congestive heart failure, and other conditions, if the patient uses aspirin, statins, and medications containing azoles, if the patient smokes, African, Caucasian and Native (Zapotecas) parental proportions, and if the patient is sensitive (requires <4mg/day) or resistant (requires >6mg/day) to warfarin. | If warfarin was indicated to manage deep vein thrombosis | phv00347719.v1.p1 |
| This subject phenotype table contains subject IDs, sex, age at the recruitment, height, weight, warfarin daily and weekly doses, if warfarin was indicated to manage deep vein thrombosis (DVT), pulmonary embolism (PE), atrial fibrillation (AF), mechanical heart valve replacement, and stroke, if the patient has diabetes, congestive heart failure, and other conditions, if the patient uses aspirin, statins, and medications containing azoles, if the patient smokes, African, Caucasian and Native (Zapotecas) parental proportions, and if the patient is sensitive (requires <4mg/day) or resistant (requires >6mg/day) to warfarin. | If the patient has diabetes (either type I or II) | phv00347725.v1.p1 |
| This subject phenotype table contains subject IDs, sex, age at the recruitment, height, weight, warfarin daily and weekly doses, if warfarin was indicated to manage deep vein thrombosis (DVT), pulmonary embolism (PE), atrial fibrillation (AF), mechanical heart valve replacement, and stroke, if the patient has diabetes, congestive heart failure, and other conditions, if the patient uses aspirin, statins, and medications containing azoles, if the patient smokes, African, Caucasian and Native (Zapotecas) parental proportions, and if the patient is sensitive (requires <4mg/day) or resistant (requires >6mg/day) to warfarin. | If warfarin was indicated to manage mechanical heart valve replacement | phv00347722.v1.p1 |
| This subject phenotype table contains subject IDs, sex, age at the recruitment, height, weight, warfarin daily and weekly doses, if warfarin was indicated to manage deep vein thrombosis (DVT), pulmonary embolism (PE), atrial fibrillation (AF), mechanical heart valve replacement, and stroke, if the patient has diabetes, congestive heart failure, and other conditions, if the patient uses aspirin, statins, and medications containing azoles, if the patient smokes, African, Caucasian and Native (Zapotecas) parental proportions, and if the patient is sensitive (requires <4mg/day) or resistant (requires >6mg/day) to warfarin. | If the patient has other conditions such as: hypertension, hypercholesterolemia, asthma, benign prostate hyperplasia, depression, glaucoma, osteoporosis, etc. | phv00347724.v1.p1 |
| This subject phenotype table contains subject IDs, sex, age at the recruitment, height, weight, warfarin daily and weekly doses, if warfarin was indicated to manage deep vein thrombosis (DVT), pulmonary embolism (PE), atrial fibrillation (AF), mechanical heart valve replacement, and stroke, if the patient has diabetes, congestive heart failure, and other conditions, if the patient uses aspirin, statins, and medications containing azoles, if the patient smokes, African, Caucasian and Native (Zapotecas) parental proportions, and if the patient is sensitive (requires <4mg/day) or resistant (requires >6mg/day) to warfarin. | If the patient uses aspirin | phv00347727.v1.p1 |
| This subject phenotype table contains subject IDs, sex, age at the recruitment, height, weight, warfarin daily and weekly doses, if warfarin was indicated to manage deep vein thrombosis (DVT), pulmonary embolism (PE), atrial fibrillation (AF), mechanical heart valve replacement, and stroke, if the patient has diabetes, congestive heart failure, and other conditions, if the patient uses aspirin, statins, and medications containing azoles, if the patient smokes, African, Caucasian and Native (Zapotecas) parental proportions, and if the patient is sensitive (requires <4mg/day) or resistant (requires >6mg/day) to warfarin. | If the patient smokes | phv00347730.v1.p1 |
| This sample attributes table contains subject IDs, sample IDs, body site, analyte type, tumor status, histological type, analysis type, genotyping and sequencing technologies, and name of the centers which conducted genotyping or sequencing. | Name of the center which conducted genotyping | phv00347743.v1.p1 |
| This data table contains a mapping of study subject IDs to sample IDs. Samples are the final preps submitted for genotyping, sequencing, and/or expression data. For example, if one patient (subject ID) gave one sample, and that sample was processed differently to generate 2 sequencing runs, there would be two rows, both using the same subject ID, but having 2 unique sample IDs. The data table also includes sample aliases and sample use. | Sample Use | phv00347711.v1.p1 |
| This data table contains a mapping of study subject IDs to sample IDs. Samples are the final preps submitted for genotyping, sequencing, and/or expression data. For example, if one patient (subject ID) gave one sample, and that sample was processed differently to generate 2 sequencing runs, there would be two rows, both using the same subject ID, but having 2 unique sample IDs. The data table also includes sample aliases and sample use. | Sample ID | phv00347708.v1.p1 |
| This sample attributes table contains subject IDs, sample IDs, body site, analyte type, tumor status, histological type, analysis type, genotyping and sequencing technologies, and name of the centers which conducted genotyping or sequencing. | Genotyping or Sequencing | phv00347740.v1.p1 |